Edgewise Therapeutics (EWTX) Prepaid Assets (2020 - 2026)
Edgewise Therapeutics' (EWTX) quarterly Prepaid Assets came in at $10.2 million in Q1 2026, up 50.64% year-on-year from $6.8 million in Q1 2025, and down 22.94% quarter-over-quarter from $13.3 million in Q4 2025.
Edgewise Therapeutics (EWTX) Prepaid Assets (2020 - 2026) Analysis & Trends
Edgewise Therapeutics has disclosed Prepaid Assets across 7 years of filings, most recently posting $10.2 million for Q1 2026.
- Prepaid Assets for Q1 2026 came in at $10.2 million, up 50.64% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.2 million (up 50.64% YoY), and the FY2025 annual result was $13.3 million, up 149.88% from the prior year.
- Prepaid Assets came in at $10.2 million for Q1 2026 at Edgewise Therapeutics, down from $13.3 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $13.3 million in Q4 2025 to a low of $2.8 million in Q1 2022.
- The 5-year median for Prepaid Assets is $7.1 million (2023), against an average of $7.4 million.
- Across the five-year window, Prepaid Assets soared 313.06% in 2022 and tumbled 38.25% in 2024, its largest moves.
- Edgewise Therapeutics' Prepaid Assets stood at $5.1 million in 2022, then jumped by 70.31% to $8.6 million in 2023, then plunged by 38.25% to $5.3 million in 2024, then soared by 149.88% to $13.3 million in 2025, then decreased by 22.94% to $10.2 million in 2026.
- The last three Prepaid Assets figures came in at $10.2 million (Q1 2026), $13.3 million (Q4 2025), and $10.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Edgewise Therapeutics | 3.52 Bn | 3.52 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.23 Mn |
| Dec 31, 2025 | 13.28 Mn |
| Sep 30, 2025 | 10.56 Mn |
| Jun 30, 2025 | 9.26 Mn |
| Mar 31, 2025 | 6.79 Mn |
| Dec 31, 2024 | 5.31 Mn |
| Sep 30, 2024 | 6.90 Mn |
| Jun 30, 2024 | 7.69 Mn |
| Mar 31, 2024 | 8.67 Mn |
| Dec 31, 2023 | 8.60 Mn |
| Sep 30, 2023 | 8.22 Mn |
| Jun 30, 2023 | 7.07 Mn |
| Mar 31, 2023 | 5.41 Mn |
| Dec 31, 2022 | 5.05 Mn |
| Sep 30, 2022 | 5.32 Mn |
| Jun 30, 2022 | 4.95 Mn |
| Mar 31, 2022 | 2.78 Mn |
| Dec 31, 2021 | 2.98 Mn |
| Sep 30, 2021 | 2.76 Mn |
| Jun 30, 2021 | 3.82 Mn |